Emergence Agitation in Pediatric Strabismus Surgery

Sponsor
Yeungnam University College of Medicine (Other)
Overall Status
Completed
CT.gov ID
NCT03807011
Collaborator
(none)
90
2
2
14.9
45
3

Study Details

Study Description

Brief Summary

This study was performed to assess the effects of continuous remifentanil infusion and single bolus administration of fentanyl on the incidence of emergence agitation in pediatrics undergoing strabismus surgery.

Condition or Disease Intervention/Treatment Phase
  • Drug: fentanyl group
  • Drug: remifentanil group
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
90 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Triple (Participant, Investigator, Outcomes Assessor)
Primary Purpose:
Prevention
Official Title:
The Effects of Remifentanil and Fentanyl on Emergence Agitation in Pediatric Strabismus Surgery
Actual Study Start Date :
Jul 7, 2017
Actual Primary Completion Date :
Oct 5, 2018
Actual Study Completion Date :
Oct 5, 2018

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: fentanyl

A bolus dose of fentanyl 2 μg/kg was administered intravenously at anesthetic induction

Drug: fentanyl group
fentanyl 2 μg/kg

Active Comparator: remifentanil

Remifentanil was continuously infused at a rate of 0.2 μg/kg/min from anesthetic induction to the end of surgery

Drug: remifentanil group
remifentanil 0.2 μg/kg/min

Outcome Measures

Primary Outcome Measures

  1. incidence of postoperative agitation [5 minutes in the recovery room]

    0=none; 1=occur

  2. incidence of postoperative agitation [30 minutes in the recovery room]

    0=none; 1=occur

  3. severity of postoperative agitation [5 minutes in the recovery room]

    Four-point agitation scale (0=calm; 1=not calm but could easily become calmed; 3=not easily calmed, moderately agitated and restless; 4=combative, excited, or disoriented)

  4. severity of postoperative agitation [30 minutes in the recovery room]

    Four-point agitation scale (0=calm; 1=not calm but could easily become calmed; 3=not easily calmed, moderately agitated and restless; 4=combative, excited, or disoriented)

Eligibility Criteria

Criteria

Ages Eligible for Study:
2 Years to 8 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • patients undergoing elective subumbilical surgery,

  • physical status was American Society of Anesthesiologists (ASA) class 1 or 2

Exclusion Criteria:
  • history of airway problem,

  • upper respiratory tract infection within 2 weeks,

  • developmental delay,

  • neurological or psychological disease,

  • history of allergy to the drugs in our protocol were excluded in this study.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Eun kyung Choi Daegu Korea (the Republic Of) Korea, Republic of 41944
2 Yeungnam University Hospital Daegu Nam-gu, Daegu Korea, Republic of 42415

Sponsors and Collaborators

  • Yeungnam University College of Medicine

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Eun Kyung Choi, Professor, Yeungnam University College of Medicine
ClinicalTrials.gov Identifier:
NCT03807011
Other Study ID Numbers:
  • YUMC 2017-04-071
First Posted:
Jan 16, 2019
Last Update Posted:
Jan 23, 2019
Last Verified:
Jan 1, 2019
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Eun Kyung Choi, Professor, Yeungnam University College of Medicine
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jan 23, 2019